Chemotherapy-induced Nausea and Vomiting Drugs Market Report

Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size, Status and Forecast 2014-2026

  • POSTDATE：Feb 25, 2020
  • PAGES：151
  • REPORT CODE：GMM485275
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Chemotherapy-induced Nausea and Vomiting Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Segmentations:

    By Player:

    • Mylan Pharmaceuticals

    • Barr Laboratories

    • Orchid Healthcare

    • Eisai

    • Aphios

    • FHoffmann La Roche

    • Especificos Stendhal

    • Heron Therapeutics

    • Tesaro

    • Helsinn

    • Acacia Pharma

    • OPKO Health

    • Mundipharma

    • F.Hoffmann La Roche

    • GlaxoSmithKline

    • Baxter Healthcare

    By Type:

    • Aloxi (palonosetron)

    • Kytril Generic (granisetron)

    • Emend (aprepitant)

    • Akynzeo (netupitant-palonosetron)

    By End-User:

    • Akynzeo (netupitant-palonosetron)

    • Akynzeo (netupitant-palonosetron)

    • Akynzeo (netupitant-palonosetron)

    • Akynzeo (netupitant-palonosetron)

    • Akynzeo (netupitant-palonosetron)

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Chemotherapy-induced Nausea and Vomiting Drugs Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Aloxi (palonosetron) from 2014 to 2026

    • 1.3.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Kytril Generic (granisetron) from 2014 to 2026

    • 1.3.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Emend (aprepitant) from 2014 to 2026

    • 1.3.4 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.4 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.4.5 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Chemotherapy-induced Nausea and Vomiting Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Chemotherapy-induced Nausea and Vomiting Drugs by Major Types

      • 3.4.1 Market Size and Growth Rate of Aloxi (palonosetron)

      • 3.4.2 Market Size and Growth Rate of Kytril Generic (granisetron)

      • 3.4.3 Market Size and Growth Rate of Emend (aprepitant)

      • 3.4.4 Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

    4 Segmentation of Chemotherapy-induced Nausea and Vomiting Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Chemotherapy-induced Nausea and Vomiting Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

      • 4.4.2 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

      • 4.4.3 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

      • 4.4.4 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

      • 4.4.5 Market Size and Growth Rate of Chemotherapy-induced Nausea and Vomiting Drugs for Akynzeo (netupitant-palonosetron)

    5 Market Analysis by Major Regions

    • 5.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Production Analysis by Top Regions

    • 5.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Analysis by Top Regions

    • 5.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 France Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Chemotherapy-induced Nausea and Vomiting Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 7.1 Germany Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 7.2 Germany Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    8. UK Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 8.1 UK Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 8.2 UK Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    9. France Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 9.1 France Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 9.2 France Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    10. Italy Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 10.1 Italy Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 10.2 Italy Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    11. Spain Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 11.1 Spain Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 11.2 Spain Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    12. Poland Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 12.1 Poland Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 12.2 Poland Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    13. Russia Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 13.1 Russia Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 13.2 Russia Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    14. Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 14.1 Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 14.2 Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    15. Turkey Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 15.1 Turkey Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 15.2 Turkey Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Top Countries

      • 16.3.1 Denmark Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 16.3.2 Finland Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 16.3.3 Norway Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 16.3.4 Sweden Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 16.3.6 Iceland Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Top Countries

      • 17.3.1 Belgium Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 17.3.2 Netherlands Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 17.3.3 Luxembourg Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Landscape Analysis by Top Countries

      • 18.3.1 Estonia Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 18.3.2 Latvia Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

      • 18.3.3 Lithuania Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Mylan Pharmaceuticals

      • 19.1.1 Mylan Pharmaceuticals Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Barr Laboratories

      • 19.2.1 Barr Laboratories Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Orchid Healthcare

      • 19.3.1 Orchid Healthcare Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Eisai

      • 19.4.1 Eisai Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Aphios

      • 19.5.1 Aphios Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 FHoffmann La Roche

      • 19.6.1 FHoffmann La Roche Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Especificos Stendhal

      • 19.7.1 Especificos Stendhal Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Heron Therapeutics

      • 19.8.1 Heron Therapeutics Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Tesaro

      • 19.9.1 Tesaro Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Helsinn

      • 19.10.1 Helsinn Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Acacia Pharma

      • 19.11.1 Acacia Pharma Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 OPKO Health

      • 19.12.1 OPKO Health Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Mundipharma

      • 19.13.1 Mundipharma Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 F.Hoffmann La Roche

      • 19.14.1 F.Hoffmann La Roche Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 GlaxoSmithKline

      • 19.15.1 GlaxoSmithKline Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 Baxter Healthcare

      • 19.16.1 Baxter Healthcare Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    The List of Tables and Figures (Totals 106 Figures and 145 Tables)

    • Figure Product Picture

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Aloxi (palonosetron) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Kytril Generic (granisetron) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Emend (aprepitant) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate of Akynzeo (netupitant-palonosetron) from 2014 to 2026

    • Figure Germany Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Chemotherapy-induced Nausea and Vomiting Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Chemotherapy-induced Nausea and Vomiting Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Chemotherapy-induced Nausea and Vomiting Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Chemotherapy-induced Nausea and Vomiting Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Chemotherapy-induced Nausea and Vomiting Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Aloxi (palonosetron)

    • Figure Market Size and Growth Rate of Kytril Generic (granisetron)

    • Figure Market Size and Growth Rate of Emend (aprepitant)

    • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Chemotherapy-induced Nausea and Vomiting Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Chemotherapy-induced Nausea and Vomiting Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

    • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

    • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

    • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

    • Figure Market Size and Growth Rate of Akynzeo (netupitant-palonosetron)

    • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Production by Major Regions

    • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Production Share by Major Regions

    • Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Production Share by Major Countries and Regions in 2014

    • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Regions

    • Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Regions

    • Table Germany Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table UK Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table France Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Italy Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Spain Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Poland Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Russia Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Turkey Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Chemotherapy-induced Nausea and Vomiting Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Germany Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Germany Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Germany Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table UK Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table UK Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table UK Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table UK Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table France Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table France Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table France Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table France Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Italy Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Italy Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Italy Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Italy Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Spain Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Spain Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Spain Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Spain Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Poland Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Poland Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Poland Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Poland Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Russia Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Russia Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Russia Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Russia Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Switzerland Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Turkey Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Turkey Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Turkey Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Chemotherapy-induced Nausea and Vomiting Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Chemotherapy-induced Nausea and Vomiting Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Mylan Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Mylan Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Mylan Pharmaceuticals

    • Table Product and Service Introduction of Mylan Pharmaceuticals

    • Table Company Profile and Development Status of Barr Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Barr Laboratories

    • Figure Sales and Growth Rate Analysis of Barr Laboratories

    • Figure Revenue and Market Share Analysis of Barr Laboratories

    • Table Product and Service Introduction of Barr Laboratories

    • Table Company Profile and Development Status of Orchid Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orchid Healthcare

    • Figure Sales and Growth Rate Analysis of Orchid Healthcare

    • Figure Revenue and Market Share Analysis of Orchid Healthcare

    • Table Product and Service Introduction of Orchid Healthcare

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Aphios

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aphios

    • Figure Sales and Growth Rate Analysis of Aphios

    • Figure Revenue and Market Share Analysis of Aphios

    • Table Product and Service Introduction of Aphios

    • Table Company Profile and Development Status of FHoffmann La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of FHoffmann La Roche

    • Figure Sales and Growth Rate Analysis of FHoffmann La Roche

    • Figure Revenue and Market Share Analysis of FHoffmann La Roche

    • Table Product and Service Introduction of FHoffmann La Roche

    • Table Company Profile and Development Status of Especificos Stendhal

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Especificos Stendhal

    • Figure Sales and Growth Rate Analysis of Especificos Stendhal

    • Figure Revenue and Market Share Analysis of Especificos Stendhal

    • Table Product and Service Introduction of Especificos Stendhal

    • Table Company Profile and Development Status of Heron Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heron Therapeutics

    • Figure Sales and Growth Rate Analysis of Heron Therapeutics

    • Figure Revenue and Market Share Analysis of Heron Therapeutics

    • Table Product and Service Introduction of Heron Therapeutics

    • Table Company Profile and Development Status of Tesaro

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Tesaro

    • Figure Sales and Growth Rate Analysis of Tesaro

    • Figure Revenue and Market Share Analysis of Tesaro

    • Table Product and Service Introduction of Tesaro

    • Table Company Profile and Development Status of Helsinn

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Helsinn

    • Figure Sales and Growth Rate Analysis of Helsinn

    • Figure Revenue and Market Share Analysis of Helsinn

    • Table Product and Service Introduction of Helsinn

    • Table Company Profile and Development Status of Acacia Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Acacia Pharma

    • Figure Sales and Growth Rate Analysis of Acacia Pharma

    • Figure Revenue and Market Share Analysis of Acacia Pharma

    • Table Product and Service Introduction of Acacia Pharma

    • Table Company Profile and Development Status of OPKO Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OPKO Health

    • Figure Sales and Growth Rate Analysis of OPKO Health

    • Figure Revenue and Market Share Analysis of OPKO Health

    • Table Product and Service Introduction of OPKO Health

    • Table Company Profile and Development Status of Mundipharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mundipharma

    • Figure Sales and Growth Rate Analysis of Mundipharma

    • Figure Revenue and Market Share Analysis of Mundipharma

    • Table Product and Service Introduction of Mundipharma

    • Table Company Profile and Development Status of F.Hoffmann La Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of F.Hoffmann La Roche

    • Figure Sales and Growth Rate Analysis of F.Hoffmann La Roche

    • Figure Revenue and Market Share Analysis of F.Hoffmann La Roche

    • Table Product and Service Introduction of F.Hoffmann La Roche

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Baxter Healthcare

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter Healthcare

    • Figure Sales and Growth Rate Analysis of Baxter Healthcare

    • Figure Revenue and Market Share Analysis of Baxter Healthcare

    • Table Product and Service Introduction of Baxter Healthcare

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US